Notice of HIDTA Designations, 61341 [2014-24176]

Download as PDF Federal Register / Vol. 79, No. 197 / Friday, October 10, 2014 / Notices Dated: October 7, 2014. James M. Cole, Deputy Attorney General. [FR Doc. 2014–24232 Filed 10–9–14; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Office of Justice Programs [OJP (NIJ) Docket No. 1675] NIJ STANDARD 0117.01 Public Safety Bomb Suit Standard National Institute of Justice, OJP, DOJ. ACTION: Notice and request for comments. AGENCY: In an effort to obtain comments from interested parties, the U.S. Department of Justice, Office of Justice Programs, National Institute of Justice (NIJ) will make available to the general public the draft: NIJ STANDARD 0117.01 Public Safety Bomb Suit Standard For Law Enforcement and Public Safety. The opportunity to provide comments on these documents is open to industry technical representatives, law enforcement agencies and organizations, research, development and scientific communities, and all other stakeholders and interested parties. Those individuals wishing to obtain and provide comments on the draft documents under consideration are directed to the following Web site: https://justnet.org/app/publiccomment/ default.aspx?Id=12 DATES: The comment period will be open until November 24, 2014. FOR FURTHER INFORMATION CONTACT: David Otterson, by telephone at 301– 240–6754, or by email at David.M.Otterson@lmco.com SUMMARY: William J. Sabol, Acting Director, National Institute of Justice. [FR Doc. 2014–24249 Filed 10–9–14; 8:45 am] BILLING CODE 4410–18–P CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive, research only license in the United States to evaluate the invention described and claimed in U.S. Patent Application No. 13/895,717, NASA Case No. KSC–13579, entitled ‘‘Treatment System and Method for Removing Halogenated Compounds from Contaminated Systems,’’ to Etana, LLC, having its principal place of business at 424 Copeland Street, Jacksonville, Florida 32235. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive, research only license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive research license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated exclusive, research only license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. DATES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of the Chief Counsel, Mail Code CC–A, NASA John F. Kennedy Space Center, Kennedy Space Center, Florida 32899. Telephone: 321–867–2076; Facsimile: 321–867– 1817. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Shelley Ford, Patent Counsel, Office of the Chief Counsel, Mail Code CC–A, NASA John F. Kennedy Space Center, Kennedy Space Center, Florida 32899. Telephone: 321–867–2076; Facsimile: 321–867–1817. Information about other NASA inventions available for licensing can be found online at http:// technology.nasa.gov/. NATIONAL AERONAUTICS AND SPACE ADMINISTRATION mstockstill on DSK4VPTVN1PROD with NOTICES [Notice (14–097)] Notice of Intent To Grant Exclusive Research License National Aeronautics and Space Administration. ACTION: Notice of Intent To Grant Exclusive Research License. AGENCY: Sumara M. Thompson-King, General Counsel. This notice is issued in accordance with 35 U.S.C. 209(e) and 37 SUMMARY: VerDate Sep<11>2014 17:09 Oct 09, 2014 Jkt 235001 [FR Doc. 2014–24221 Filed 10–9–14; 8:45 am] BILLING CODE 7510–13–P PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 61341 OFFICE OF NATIONAL DRUG CONTROL POLICY Notice of HIDTA Designations Heading: Designation of 26 Counties/ Cities as High Intensity Drug Trafficking Areas. SUMMARY: The Director of the Office of National Drug Control Policy designated 26 additional counties/cities as High Intensity Drug Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties/cities are (1) Madison and Nelson Counties in Kentucky, Tazewell County in Virginia, and Harrison County in West Virginia as part of the Appalachia HIDTA; (2) Pasco County in Florida as part of the Central Florida HIDTA; (3) Trinity and Siskiyou Counties in California as part of the Central Valley California HIDTA; (4) Brazoria County in Texas as part of the Houston HIDTA; (5) Rockingham County in New Hampshire as part of the New England HIDTA; (6) Chautauqua, Dutchess, Putnam, and Rockland Counties in New York as part of the New York/New Jersey HIDTA; (7) Ada and Canyon Counties in Idaho, and Malheur County in Oregon as part of the Oregon HIDTA; (8) Gallatin County in Montana as part of the Rocky Mountain HIDTA; (9) Potter and Randall Counties in Texas as part of the Texoma HIDTA; and (10) Berkeley County in West Virginia and the Cities of Chesapeake, Hampton, Newport News, Norfolk, Portsmouth, and Virginia Beach in Virginia as part of the Washington/ Baltimore HIDTA. FOR FURTHER INFORMATION CONTACT: Questions regarding this notice should be directed to Michael K. Gottlieb, National HIDTA Program Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 395–4868. Dated: September 29, 2014. Submitted October 6, 2014. Daniel Rader, Deputy General Counsel. [FR Doc. 2014–24176 Filed 10–9–14; 8:45 am] BILLING CODE 3280–F5–P NATIONAL SCIENCE FOUNDATION Proposal Review Panel for Materials Research; Notice of Meeting In accordance with the Federal Advisory Committee Act (Pub., L. 92– 463 as amended), the National Science Foundation announces the following meeting: Name: Proposal Review Panel for Materials Research (DMR) #1203. Dates & Times: E:\FR\FM\10OCN1.SGM 10OCN1

Agencies

[Federal Register Volume 79, Number 197 (Friday, October 10, 2014)]
[Notices]
[Page 61341]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-24176]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Notice of HIDTA Designations

    Heading: Designation of 26 Counties/Cities as High Intensity Drug 
Trafficking Areas.
SUMMARY: The Director of the Office of National Drug Control Policy 
designated 26 additional counties/cities as High Intensity Drug 
Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties/
cities are (1) Madison and Nelson Counties in Kentucky, Tazewell County 
in Virginia, and Harrison County in West Virginia as part of the 
Appalachia HIDTA; (2) Pasco County in Florida as part of the Central 
Florida HIDTA; (3) Trinity and Siskiyou Counties in California as part 
of the Central Valley California HIDTA; (4) Brazoria County in Texas as 
part of the Houston HIDTA; (5) Rockingham County in New Hampshire as 
part of the New England HIDTA; (6) Chautauqua, Dutchess, Putnam, and 
Rockland Counties in New York as part of the New York/New Jersey HIDTA; 
(7) Ada and Canyon Counties in Idaho, and Malheur County in Oregon as 
part of the Oregon HIDTA; (8) Gallatin County in Montana as part of the 
Rocky Mountain HIDTA; (9) Potter and Randall Counties in Texas as part 
of the Texoma HIDTA; and (10) Berkeley County in West Virginia and the 
Cities of Chesapeake, Hampton, Newport News, Norfolk, Portsmouth, and 
Virginia Beach in Virginia as part of the Washington/Baltimore HIDTA.

FOR FURTHER INFORMATION CONTACT: Questions regarding this notice should 
be directed to Michael K. Gottlieb, National HIDTA Program Director, 
Office of National Drug Control Policy, Executive Office of the 
President, Washington, DC 20503; (202) 395-4868.

    Dated: September 29, 2014.

    Submitted October 6, 2014.
Daniel Rader,
Deputy General Counsel.
[FR Doc. 2014-24176 Filed 10-9-14; 8:45 am]
BILLING CODE 3280-F5-P